Which has higher earnings & valuation, HNST or WALD?

Honest has higher revenue and earnings than Waldencast. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Honest $371.32M 1.58 -$15.69M -$0.11 N/A Waldencast $272.07M 0.55 -$229.75M N/A N/A

Is HNST or WALD more profitable?

Waldencast has a net margin of 0.00% compared to Honest's net margin of -3.56%. Honest's return on equity of 4.31% beat Waldencast's return on equity. Company Net Margins Return on Equity Return on Assets Honest -3.56% 4.31% 3.33% Waldencast N/A N/A N/A

Does the media prefer HNST or WALD?

In the previous week, Honest had 2 more articles in the media than Waldencast. MarketBeat recorded 4 mentions for Honest and 2 mentions for Waldencast. Honest's average media sentiment score of 1.24 beat Waldencast's score of 0.00 indicating that Honest is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Honest 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Waldencast 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher valuation and earnings, WALD or PRE?

Prenetics Global has lower revenue, but higher earnings than Waldencast. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Waldencast $272.07M 0.55 -$229.75M N/A N/A Prenetics Global $92.39M 4.42 -$37.71M -$4.16 N/A

Does the media refer more to WALD or PRE?

In the previous week, Prenetics Global had 3 more articles in the media than Waldencast. MarketBeat recorded 5 mentions for Prenetics Global and 2 mentions for Waldencast. Prenetics Global's average media sentiment score of 0.32 beat Waldencast's score of 0.00 indicating that Prenetics Global is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Waldencast 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Prenetics Global 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate WALD or USNA?

Waldencast presently has a consensus target price of $2.33, indicating a potential upside of 101.15%. Given Waldencast's stronger consensus rating and higher probable upside, analysts clearly believe Waldencast is more favorable than USANA Health Sciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Waldencast 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 USANA Health Sciences 2 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation and earnings, WALD or USNA?

USANA Health Sciences has higher revenue and earnings than Waldencast. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Waldencast $272.07M 0.55 -$229.75M N/A N/A USANA Health Sciences $925.26M 0.28 $10.76M -$1.21 N/A

Do analysts rate YSG or WALD?

Waldencast has a consensus target price of $2.33, suggesting a potential upside of 101.15%. Given Waldencast's stronger consensus rating and higher possible upside, analysts clearly believe Waldencast is more favorable than Yatsen. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Yatsen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Waldencast 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25

Which has stronger valuation and earnings, YSG or WALD?

Yatsen has higher revenue and earnings than Waldencast. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Yatsen $614.62M 0.38 -$11.56M -$0.32 N/A Waldencast $272.07M 0.55 -$229.75M N/A N/A

Is YSG or WALD more profitable?

Waldencast has a net margin of 0.00% compared to Yatsen's net margin of -4.63%. Waldencast's return on equity of 0.00% beat Yatsen's return on equity. Company Net Margins Return on Equity Return on Assets Yatsen -4.63% -7.26% -5.42% Waldencast N/A N/A N/A

Which has preferable earnings & valuation, WALD or NAGE?

Niagen Bioscience has lower revenue, but higher earnings than Waldencast. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Waldencast $272.07M 0.55 -$229.75M N/A N/A Niagen Bioscience $129.42M 1.84 $17.38M $0.18 16.61

Does the media favor WALD or NAGE?

In the previous week, Niagen Bioscience had 1 more articles in the media than Waldencast. MarketBeat recorded 3 mentions for Niagen Bioscience and 2 mentions for Waldencast. Waldencast's average media sentiment score of 0.00 equaled Niagen Bioscience'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Waldencast 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Niagen Bioscience 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Waldencast (WALD) Competitors

$1.16 +0.01 (+0.87%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$1.16 0.00 (-0.43%)

As of 09/18/2026 07:30 PM Eastern

Compare

WALD vs. HNST, PRE, USNA, YSG, and NAGE

Should you buy Waldencast stock or one of its competitors? Waldencast's main competitors and comparable companies include Honest (HNST), Prenetics Global (PRE), USANA Health Sciences (USNA), Yatsen (YSG), and Niagen Bioscience (NAGE). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "personal care products" industry.

How does Waldencast compare to Honest?

Honest (NASDAQ:HNST) and Waldencast (NASDAQ:WALD) are both small-cap consumer staples companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, institutional ownership, valuation, profitability, media sentiment, analyst recommendations, earnings and dividends.

45.5% of Honest shares are owned by institutional investors. Comparatively, 42.0% of Waldencast shares are owned by institutional investors. 9.4% of Honest shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Honest presently has a consensus price target of $4.84, suggesting a potential downside of 9.19%. Waldencast has a consensus price target of $2.33, suggesting a potential upside of 101.15%. Given Waldencast's stronger consensus rating and higher probable upside, analysts plainly believe Waldencast is more favorable than Honest.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Honest	2 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.22
Waldencast	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Waldencast has a net margin of 0.00% compared to Honest's net margin of -3.56%. Honest's return on equity of 4.31% beat Waldencast's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Honest	-3.56%	4.31%	3.33%
Waldencast	N/A	N/A	N/A

Honest has a beta of 2.24, indicating that its stock price is 124% more volatile than the broader market. Comparatively, Waldencast has a beta of -0.15, indicating that its stock price is 115% less volatile than the broader market.

In the previous week, Honest had 2 more articles in the media than Waldencast. MarketBeat recorded 4 mentions for Honest and 2 mentions for Waldencast. Honest's average media sentiment score of 1.24 beat Waldencast's score of 0.00 indicating that Honest is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Honest	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Waldencast	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Honest has higher revenue and earnings than Waldencast.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Honest	$371.32M	1.58	-$15.69M	-$0.11	N/A
Waldencast	$272.07M	0.55	-$229.75M	N/A	N/A

Summary

Honest beats Waldencast on 11 of the 14 factors compared between the two stocks.

How does Waldencast compare to Prenetics Global?

Waldencast (NASDAQ:WALD) and Prenetics Global (NASDAQ:PRE) are both small-cap consumer staples companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, dividends, valuation, risk, profitability, earnings and analyst recommendations.

Waldencast has a net margin of 0.00% compared to Prenetics Global's net margin of -47.43%. Waldencast's return on equity of 0.00% beat Prenetics Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Waldencast	N/A	N/A	N/A
Prenetics Global	-47.43%	-21.41%	-15.56%

In the previous week, Prenetics Global had 3 more articles in the media than Waldencast. MarketBeat recorded 5 mentions for Prenetics Global and 2 mentions for Waldencast. Prenetics Global's average media sentiment score of 0.32 beat Waldencast's score of 0.00 indicating that Prenetics Global is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Waldencast	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Prenetics Global	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Prenetics Global has lower revenue, but higher earnings than Waldencast.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Waldencast	$272.07M	0.55	-$229.75M	N/A	N/A
Prenetics Global	$92.39M	4.42	-$37.71M	-$4.16	N/A

Waldencast presently has a consensus price target of $2.33, suggesting a potential upside of 101.15%. Prenetics Global has a consensus price target of $35.67, suggesting a potential upside of 47.44%. Given Waldencast's higher probable upside, equities research analysts plainly believe Waldencast is more favorable than Prenetics Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Waldencast	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Prenetics Global	1 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.71

Waldencast has a beta of -0.15, meaning that its stock price is 115% less volatile than the broader market. Comparatively, Prenetics Global has a beta of 0.31, meaning that its stock price is 69% less volatile than the broader market.

42.0% of Waldencast shares are owned by institutional investors. Comparatively, 25.0% of Prenetics Global shares are owned by institutional investors. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Prenetics Global beats Waldencast on 7 of the 13 factors compared between the two stocks.

How does Waldencast compare to USANA Health Sciences?

Waldencast (NASDAQ:WALD) and USANA Health Sciences (NYSE:USNA) are both small-cap consumer staples companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, dividends, institutional ownership, earnings, media sentiment, valuation and profitability.

Waldencast presently has a consensus target price of $2.33, indicating a potential upside of 101.15%. Given Waldencast's stronger consensus rating and higher probable upside, analysts clearly believe Waldencast is more favorable than USANA Health Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Waldencast	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
USANA Health Sciences	2 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Waldencast has a beta of -0.15, indicating that its share price is 115% less volatile than the broader market. Comparatively, USANA Health Sciences has a beta of 0.68, indicating that its share price is 32% less volatile than the broader market.

Waldencast has a net margin of 0.00% compared to USANA Health Sciences' net margin of -2.43%. USANA Health Sciences' return on equity of 3.41% beat Waldencast's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Waldencast	N/A	N/A	N/A
USANA Health Sciences	-2.43%	3.41%	2.50%

In the previous week, Waldencast had 2 more articles in the media than USANA Health Sciences. MarketBeat recorded 2 mentions for Waldencast and 0 mentions for USANA Health Sciences. Waldencast's average media sentiment score of 0.00 equaled USANA Health Sciences'average media sentiment score.

Company	Overall Sentiment
Waldencast	Neutral
USANA Health Sciences	Neutral

USANA Health Sciences has higher revenue and earnings than Waldencast.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Waldencast	$272.07M	0.55	-$229.75M	N/A	N/A
USANA Health Sciences	$925.26M	0.28	$10.76M	-$1.21	N/A

42.0% of Waldencast shares are held by institutional investors. Comparatively, 54.3% of USANA Health Sciences shares are held by institutional investors. 0.8% of USANA Health Sciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

USANA Health Sciences beats Waldencast on 7 of the 13 factors compared between the two stocks.

How does Waldencast compare to Yatsen?

Yatsen (NYSE:YSG) and Waldencast (NASDAQ:WALD) are both small-cap consumer staples companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, valuation, profitability and media sentiment.

42.0% of Waldencast shares are owned by institutional investors. 29.0% of Yatsen shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Waldencast has a consensus target price of $2.33, suggesting a potential upside of 101.15%. Given Waldencast's stronger consensus rating and higher possible upside, analysts clearly believe Waldencast is more favorable than Yatsen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Yatsen	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Waldencast	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Yatsen has higher revenue and earnings than Waldencast.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Yatsen	$614.62M	0.38	-$11.56M	-$0.32	N/A
Waldencast	$272.07M	0.55	-$229.75M	N/A	N/A

Yatsen has a beta of -1.54, suggesting that its stock price is 254% less volatile than the broader market. Comparatively, Waldencast has a beta of -0.15, suggesting that its stock price is 115% less volatile than the broader market.

In the previous week, Waldencast had 2 more articles in the media than Yatsen. MarketBeat recorded 2 mentions for Waldencast and 0 mentions for Yatsen. Yatsen's average media sentiment score of 0.05 beat Waldencast's score of 0.00 indicating that Yatsen is being referred to more favorably in the media.

Company	Overall Sentiment
Yatsen	Neutral
Waldencast	Neutral

Waldencast has a net margin of 0.00% compared to Yatsen's net margin of -4.63%. Waldencast's return on equity of 0.00% beat Yatsen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Yatsen	-4.63%	-7.26%	-5.42%
Waldencast	N/A	N/A	N/A

Summary

Waldencast beats Yatsen on 10 of the 14 factors compared between the two stocks.

How does Waldencast compare to Niagen Bioscience?

Waldencast (NASDAQ:WALD) and Niagen Bioscience (NASDAQ:NAGE) are both small-cap consumer staples companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, profitability, valuation, media sentiment, dividends and risk.

Waldencast presently has a consensus price target of $2.33, suggesting a potential upside of 101.15%. Niagen Bioscience has a consensus price target of $10.33, suggesting a potential upside of 245.60%. Given Niagen Bioscience's stronger consensus rating and higher probable upside, analysts plainly believe Niagen Bioscience is more favorable than Waldencast.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Waldencast	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Niagen Bioscience	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.00

In the previous week, Niagen Bioscience had 1 more articles in the media than Waldencast. MarketBeat recorded 3 mentions for Niagen Bioscience and 2 mentions for Waldencast. Waldencast's average media sentiment score of 0.00 equaled Niagen Bioscience'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Waldencast	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Niagen Bioscience	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Niagen Bioscience has a net margin of 12.39% compared to Waldencast's net margin of 0.00%. Niagen Bioscience's return on equity of 17.95% beat Waldencast's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Waldencast	N/A	N/A	N/A
Niagen Bioscience	12.39%	17.95%	13.17%

Waldencast has a beta of -0.15, meaning that its share price is 115% less volatile than the broader market. Comparatively, Niagen Bioscience has a beta of 2.09, meaning that its share price is 109% more volatile than the broader market.

42.0% of Waldencast shares are owned by institutional investors. Comparatively, 15.4% of Niagen Bioscience shares are owned by institutional investors. 10.0% of Niagen Bioscience shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Niagen Bioscience has lower revenue, but higher earnings than Waldencast.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Waldencast	$272.07M	0.55	-$229.75M	N/A	N/A
Niagen Bioscience	$129.42M	1.84	$17.38M	$0.18	16.61

Summary

Niagen Bioscience beats Waldencast on 12 of the 14 factors compared between the two stocks.

Get Waldencast News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WALD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

WALD vs. The Competition

Export

Metric	Waldencast	Personal Care Products Industry	Consumer Staples Sector	NASDAQ Exchange
Market Cap	$149.18M	$22.84B	$15.55B	$12.95B
Dividend Yield	N/A	4.70%	3.25%	12.80%
P/E Ratio	N/A	20.08	14.15	25.40
Price / Sales	0.55	12.69	262,948.98	82.03
Price / Cash	18.09	26.25	56.66	51.42
Price / Book	0.30	2.88	4.69	6.33
Net Income	-$229.75M	$1.13B	$836.60M	$358.33M
7 Day Performance	-11.45%	-2.39%	-0.95%	1.12%
1 Month Performance	-14.07%	-2.09%	-2.88%	-2.39%
1 Year Performance	-44.23%	-14.84%	10.46%	5.35%

Waldencast Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
WALD Waldencast	2.2822 of 5 stars	$1.16 +0.9%	$2.33 +101.1%	-44.2%	$149.18M	$272.07M	N/A	367	Upcoming Earnings
HNST Honest	2.1779 of 5 stars	$5.31 -0.3%	$4.84 -8.8%	+36.0%	$583.97M	$342.01M	N/A	174	News Coverage Positive News
PRE Prenetics Global	3.8153 of 5 stars	$24.00 -0.8%	$35.67 +48.6%	+101.6%	$404.98M	$154.59M	N/A	98	News Coverage Analyst Forecast
USNA USANA Health Sciences	1.6483 of 5 stars	$14.26 -0.6%	N/A	-52.4%	$263.48M	$913.36M	N/A	1,570
YSG Yatsen	0.4928 of 5 stars	$2.70 +2.7%	N/A	-74.6%	$253.27M	$4.54B	N/A	1,623

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:WALD) was last updated on 9/20/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Waldencast (WALD) Competitors

WALD vs. HNST, PRE, USNA, YSG, and NAGE

How does Waldencast compare to Honest?

Summary

How does Waldencast compare to Prenetics Global?

Summary

How does Waldencast compare to USANA Health Sciences?

Summary

How does Waldencast compare to Yatsen?

Summary

How does Waldencast compare to Niagen Bioscience?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

WALD vs. The Competition

Waldencast Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Waldencast (WALD) Competitors

WALD vs. HNST, PRE, USNA, YSG, and NAGE

How does Waldencast compare to Honest?

Do insiders and institutionals have more ownership in HNST or WALD?

Do analysts rate HNST or WALD?

Is HNST or WALD more profitable?

Which has more volatility and risk, HNST or WALD?

Does the media prefer HNST or WALD?

Which has higher earnings & valuation, HNST or WALD?

Summary

How does Waldencast compare to Prenetics Global?

Is WALD or PRE more profitable?

Does the media refer more to WALD or PRE?

Which has higher valuation and earnings, WALD or PRE?

Do analysts rate WALD or PRE?

Which has more volatility & risk, WALD or PRE?

Do insiders & institutionals hold more shares of WALD or PRE?

Summary

How does Waldencast compare to USANA Health Sciences?

Do analysts rate WALD or USNA?

Which has more volatility & risk, WALD or USNA?

Is WALD or USNA more profitable?

Does the media refer more to WALD or USNA?

Which has better valuation and earnings, WALD or USNA?

Do insiders & institutionals believe in WALD or USNA?

Summary

How does Waldencast compare to Yatsen?

Do insiders and institutionals hold more shares of YSG or WALD?

Do analysts rate YSG or WALD?

Which has stronger valuation and earnings, YSG or WALD?

Which has more risk & volatility, YSG or WALD?

Does the media prefer YSG or WALD?

Is YSG or WALD more profitable?

Summary

How does Waldencast compare to Niagen Bioscience?

Do analysts rate WALD or NAGE?

Does the media favor WALD or NAGE?

Is WALD or NAGE more profitable?

Which has more volatility & risk, WALD or NAGE?

Do insiders & institutionals have more ownership in WALD or NAGE?

Which has preferable earnings & valuation, WALD or NAGE?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

WALD vs. The Competition

Waldencast Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools